Astragalin promotes HSCs ferroptosis through NCOA4 mediated ferritinophagy to alleviate liver fibrosis in zebrafish and mice

作者：Yuhua Wang, Shanshan Kuang, Ké Li, Shuni Chen, Min Yang, Kaili Deng, Min Li, Shuwen Xie, Qing Chen, Jin Fu Wen, Chuying Zhou, Weidong Cheng, Sha Huang, Zhiping Lv · 发表于：Communications Biology · 年份：2025 · DOI：10.1038/s42003-025-08421-0 · 被引用次数：8 · 研究领域：Ferroptosis and cancer prognosis、MicroRNA in disease regulation、Drug Transport and Resistance Mechanisms

Liver fibrosis is pathological progression of chronic liver disease. Recent research has focused on the activation of hepatic stellate cells (HSCs), highlighting their potential as targets for mitigating fibrosis. While herbal medicines and natural active ingredients have shown promising anti-fibrotic effects in clinical treatments, the impact of Astragalin (Ag) remains unexplored. In this study, we established in vivo and in vitro studies, employing fluorescence probe staining, transmission electron microscopy, and various analytical techniques. The results demonstrated Ag operates within a wide range of safe therapeutic doses in zebrafish and effectively alleviates liver fibrosis. Further experiments demonstrated that Ag induced HSCs ferroptosis via this pathway, leading to iron overload and ultimately alleviating liver fibrosis. In general, this study demonstrated that Ag promotes HSCs ferroptosis through NCOA4-mediated ferritinophagy, clarifying its mechanism in treating liver fibrosis and positioning Ag as a promising candidate for future clinical interventions.